CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.

As of 06/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  07/12/2017
Outstanding shares:  33,987,736
Average volume:  375,005
Market cap:   $172,997,576
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD3BX23
Valuation   (See tab for details)
PE ratio:   4.51
PB ratio:   1.24
PS ratio:   1.72
Return on equity:   27.40%
Net income %:   40.25%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy